Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Hepacivirus Medicine & Life Sciences
Infection Medicine & Life Sciences
Neutralizing Antibodies Medicine & Life Sciences
Vaccines Medicine & Life Sciences
NF-E2-Related Factor 2 Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
HIV Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2006 2017

Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection

Cox, A. L. , Osburn, W. & 21 others Rodrigo, C., Walker, M. R., Leung, P., Eltahla, A. A., Grebely, J., Dore, G. J., Applegate, T., Page, K., Dwivedi, S., Bruneau, J., Morris, M. D., Kim, A. Y., Schinkel, J., Shoukry, N. H., Lauer, G. M., Maher, L., Hellard, M., Prins, M., Luciani, F., Lloyd, A. R. & Bull, R. A. Apr 1 2017 In : Infection, Genetics and Evolution. 49, p. 88-96 9 p.

Research output: Contribution to journalArticle

Hepatitis C
Neutralizing Antibodies
Epitopes
Glycoproteins
Infection

A hepatitis C virus envelope polymorphism confers resistance to neutralization by polyclonal sera and broadly neutralizing monoclonal antibodies

Wasilewski, L. N., El-Diwany, R., Munshaw, S., Snider, A. E., Brady, J. K., Osburn, W. O., Ray, S. C. & Bailey, J. R. 2016 In : Journal of Virology. 90, 7, p. 3773-3782 10 p.

Research output: Contribution to journalArticle

Neutralizing Antibodies
Hepacivirus
Monoclonal Antibodies
Serum
Vaccines

Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia

Cox, A. L. , Osburn, W. & 20 others Rodrigo, C., Eltahla, A. A., Bull, R. A., Grebely, J., Dore, G. J., Applegate, T., Page, K., Bruneau, J., Morris, M. D., Kim, A. Y., Schinkel, J., Shoukry, N. H., Lauer, G. M., Maher, L., Hellard, M., Prins, M., Estes, C., Razavi, H., Lloyd, A. R. & Luciani, F. Nov 1 2016 In : Journal of Infectious Diseases. 214, 9, p. 1383-1389 7 p.

Research output: Contribution to journalArticle

Hepacivirus
HIV
Bayes Theorem
RNA Viruses
Heroin

Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: The InC3 Study

Rodrigo, C., Eltahla, A. A., Bull, R. A., Luciani, F., Grebely, J., Dore, G. J., Applegate, T., Page, K., Bruneau, J., Morris, M. D., Cox, A. L., Osburn, W., Kim, A. Y., Shoukry, N. H., Lauer, G. M., Maher, L., Schinkel, J., Prins, M., Hellard, M. & Lloyd, A. R. 2016 In : Journal of Viral Hepatitis.

Research output: Contribution to journalArticle

Hepacivirus
Genome
Infection
Hepatitis C
Molecular Epidemiology

Use of Hepatitis C Virus (HCV) Immunoglobulin G Antibody Avidity as a Biomarker to Estimate the Population-Level Incidence of HCV Infection

Patel, E. U., Cox, A. L., Mehta, S. H., Boon, D., Mullis, C. E., Astemborski, J., Osburn, W. O., Quinn, J., Redd, A. D., Kirk, G. D., Thomas, D. L., Quinn, T. C. & Laeyendecker, O. Aug 1 2016 In : Journal of Infectious Diseases. 214, 3, p. 344-352 9 p.

Research output: Contribution to journalArticle

Antibody Affinity
Hepacivirus
Immunoglobulin G
Biological Markers
Incidence